Login / Signup

Adequacy of EBUS-TBNA specimen for mutation analysis of lung cancer.

Tugba CicekAyperi ÖztürkAydın YılmazZafer AktasFunda DemiragNalan Akyurek
Published in: The clinical respiratory journal (2019)
The study demonstrated that EBUS-TBNA provides adequate material for mutation analysis in patients with newly diagnosed adenocarcinoma or NOS lung cancer.
Keyphrases
  • newly diagnosed
  • nitric oxide
  • rectal cancer